MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Altus Clinical Research Reports Multimillion-Dollar Growth and a Clean FDA Inspection Record
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Kaplan Fox & Kilsheimer LLP Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to the Lead Plaintiff Deadline on September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
OS Therapies Announces Full Alignment with UK MHRA and EU EMA for Conditional Marketing Authorisation Application Filing
Via Newsfile
Tickers OSTX
Exposures Product Safety
News headline image
Stem Cell Facelift for Facial Rejuvenation: Korea vs US Comparison Released
Via Press Release Distribution Service
Exposures Product Safety
News headline image
Panic Disorder Treatment: What Actually Helps Prevent Panic Attacks? ↗
Via Talk Markets
Exposures Product Safety
News headline image
Regeneron Highlights Dupixent Growth, Cemdisiran Catalysts and EYLEA HD Momentum ↗
Via MarketBeat
Topics Intellectual Property
Tickers MS REGN
Exposures Intellectual Property Product Safety
News headline image
Frost & Sullivan Published the White Book on the Current Landscape and Future Trends of the Gut Microbiota Industry
Via Newsfile
Exposures Product Safety
News headline image
CRISPR Therapeutics Eyes CASGEVY Growth, Year-End Pipeline Catalysts ↗
Via MarketBeat
Topics Intellectual Property
Tickers CRSP MS
Exposures Intellectual Property Product Safety
News headline image
Kaplan Fox & Kilsheimer LLP Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
News headline image
AgelessRx Publishes Comprehensive New Low Dose Naltrexone Resource
Via GetFeatured
Exposures Product Safety
News headline image
Did You Lose Money Investing in Beta Bionics, Inc.? Robbins LLP Urges Investors with Significant Losses to Contact the Firm for Information About Their Rights Against BBNX
Via Newsfile
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
NetworkNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in NetworkNewsAudio APR Highlighting FDA Clearance of Lucid-MS IND
Via Investor Brand Network
Tickers QNTM
Exposures Product Safety
News headline image
Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma
Via Newsfile
Tickers PHIO
Exposures Product Safety
News headline image
Ambien Prescription Online for Sleep Support and Treatment from A2ZRx ↗
Via Talk Markets
Exposures Product Safety
News headline image
3 Small-Cap Biotechs With Binary Catalysts on the Calendar ↗
Via MarketBeat
Tickers AMD CAPR IVVD KOD
Exposures COVID-19 Product Safety
News headline image
Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands ↗
Via MarketBeat
Tickers GERN
Exposures Product Safety
News headline image
AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears ↗
Via MarketBeat
Topics ETFs
Tickers AZN
Exposures Product Safety
News headline image
Where Was the Light Measured? NuYOU360 Publishes Its Irradiance Testing Positions and Asks the Red Light Therapy Industry to Do the Same
Via AB Newswire
Exposures Product Safety
News headline image
Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference ↗
Via MarketBeat
Tickers VRTX
Exposures Product Safety
News headline image
Tonix Pharmaceuticals Targets TONMYA Growth as Lyme Prevention Trial Nears ↗
Via MarketBeat
Tickers TNXP
Exposures Product Safety
News headline image
He Flew, Sailed the World and Saw the Lord’s Guidance Along the Way
Via AB Newswire
Topics Product Recall
Tickers AMZN
Exposures Legal Product Safety
News headline image
Kaplan Fox Class Action Reminder: Capricor Therapeutics, Inc. (NASDAQ: CAPR) Lead Plaintiff Deadline is September 28, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BAC CAPR
Exposures Financial Legal Product Safety
News headline image
Exelixis Stock Slips as FDA Delays Cancer Drug Review, Analyst Weighs In ↗
Via Benzinga
Exposures Product Safety
News headline image
FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
Via PRLog
Exposures Product Safety
News headline image
Kaplan Fox Encourages Investors of Medline Inc. (NASDAQ: MDLN) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations
Via NewMediaWire
Tickers BAC MDLN
Exposures Product Safety
News headline image
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 3, 2026
Via NewMediaWire
Topics Lawsuit
Tickers BBNX
Exposures Financial Legal Product Safety
News headline image
Kaplan Fox Notifies Fulcrum Therapeutics, Inc. (NASDAQ: FULC) Investors of an Investigation Into Possible Securities Law Violations
Via NewMediaWire
Tickers FULC
Exposures Product Safety
News headline image
Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay ↗
Via Investor's Business Daily
Exposures Product Safety
News headline image
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms ↗
Via MarketBeat
Topics Artificial Intelligence
Tickers INO PLTR
Exposures Artificial Intelligence Product Safety
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story